Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Journal of Immunological Methods
|
May 25, 1984
Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium
H C Stevenson, E Schlick, R Griffith, et al.
Scandinavian Journal of Immunology
|
September 1, 1981
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives
H C Stevenson, P Katz, D G Wright, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1985
A phase I trial of recombinant gamma interferon in patients with cancer
K A Foon, S A Sherwin, P G Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1987
Expression and secretion of type beta transforming growth factor by activated human macrophages
R K Assoian, B E Fleurdelys, H C Stevenson, et al.
Journal of Leukocyte Biology
|
June 1, 1989
Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli
J A Warner, S P Peters, L M Lichtenstein, et al.
Immunopharmacology and Immunotoxicology
|
January 1, 1987
Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferon
G W Stevenson, S Hall, S J Rudnick, et al.
The Journal of Clinical Investigation
|
September 1, 1983
Characterization of a human blood monocyte subset with low peroxidase activity
Y Akiyama, P J Miller, G B Thurman, et al.
Journal of Biological Response Modifiers
|
January 1, 1984
A trial of autologous plasma perfusion over protein A in patients with breast cancer
M F Fer, J Beman, H C Stevenson, et al.
Cancer Research
|
November 15, 1990
Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen
J W Clark, J W Smith, R G Steis, et al.
Cancer Research
|
January 1, 1990
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer
W J Urba, R G Steis, D L Longo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Journal of Immunological Methods
|
May 25, 1984
Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium
H C Stevenson, E Schlick, R Griffith, et al.
Scandinavian Journal of Immunology
|
September 1, 1981
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives
H C Stevenson, P Katz, D G Wright, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1985
A phase I trial of recombinant gamma interferon in patients with cancer
K A Foon, S A Sherwin, P G Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1987
Expression and secretion of type beta transforming growth factor by activated human macrophages
R K Assoian, B E Fleurdelys, H C Stevenson, et al.
Journal of Leukocyte Biology
|
June 1, 1989
Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli
J A Warner, S P Peters, L M Lichtenstein, et al.
Immunopharmacology and Immunotoxicology
|
January 1, 1987
Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferon
G W Stevenson, S Hall, S J Rudnick, et al.
The Journal of Clinical Investigation
|
September 1, 1983
Characterization of a human blood monocyte subset with low peroxidase activity
Y Akiyama, P J Miller, G B Thurman, et al.
Journal of Biological Response Modifiers
|
January 1, 1984
A trial of autologous plasma perfusion over protein A in patients with breast cancer
M F Fer, J Beman, H C Stevenson, et al.
Cancer Research
|
November 15, 1990
Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen
J W Clark, J W Smith, R G Steis, et al.
Cancer Research
|
January 1, 1990
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer
W J Urba, R G Steis, D L Longo, et al.
Page
of 9